Tidal Investments LLC Makes New $7.63 Million Investment in Tempus AI, Inc. (NASDAQ:TEM)

Tidal Investments LLC bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 134,857 shares of the company's stock, valued at approximately $7,633,000. Tidal Investments LLC owned about 0.09% of Tempus AI at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. Kovitz Investment Group Partners LLC acquired a new stake in shares of Tempus AI during the 3rd quarter worth about $1,367,000. Sumitomo Mitsui Trust Group Inc. boosted its stake in Tempus AI by 1,591.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock worth $68,922,000 after buying an additional 1,145,698 shares during the period. Captrust Financial Advisors acquired a new stake in shares of Tempus AI during the third quarter valued at about $2,726,000. Sigma Planning Corp purchased a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $1,323,000. Finally, Dakota Wealth Management acquired a new position in shares of Tempus AI in the 3rd quarter worth approximately $1,185,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on TEM shares. Guggenheim assumed coverage on Tempus AI in a research report on Monday. They issued a "buy" rating and a $74.00 target price on the stock. Wolfe Research started coverage on shares of Tempus AI in a research note on Friday. They issued an "outperform" rating and a $60.00 price objective for the company. Piper Sandler reaffirmed a "neutral" rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Loop Capital raised their price target on shares of Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a research report on Tuesday, October 15th. Finally, Bank of America boosted their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research note on Friday. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $56.00.

Insider Transactions at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the transaction, the insider now directly owns 16,164,449 shares of the company's stock, valued at $694,263,084.55. This trade represents a 2.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Tempus AI Stock Down 2.1 %

Tempus AI stock traded down $0.87 during midday trading on Friday, reaching $41.12. The company's stock had a trading volume of 4,669,208 shares, compared to its average volume of 1,423,409. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The stock's 50-day moving average is $52.88. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $79.49.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.